9-Me-BC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
9-Me-BC (9-Methyl-β-carboline) is a Monoamine oxidase inhibitor, neuroprotective agent. Synthetic indole alkaloid derivative targeting dopaminergic neuroprotection. It is researched for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity. Common dosages range from 15-30 mg daily administered once daily.
What Is 9-Me-BC?
9-Me-BC (9-Methyl-β-carboline) is a Monoamine oxidase inhibitor, neuroprotective agent. Synthetic indole alkaloid derivative targeting dopaminergic neuroprotection. Also known as 9-MBC, 9-methyl-beta-carboline, it has been studied for its potential effects on dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity.
Dual mechanism of MAO inhibition plus neurotrophic factor stimulation makes it unique for dopaminergic restoration — one of the few compounds that both preserves existing dopamine AND grows new dopaminergic neurons. In the research community, 9-Me-BC has gained attention for its distinctive profile.
How Does 9-Me-BC Work?
Inhibits MAO-A (IC50: 1 μM) and MAO-B (IC50: 15.5 μM), preventing dopamine degradation and extending its activity. Simultaneously stimulates neurotrophic factor gene expression including BDNF, GDNF, and ARTN through the PI3K/Akt signaling pathway, promoting both dopaminergic neuron survival and new dendritic growth.
This multi-pathway activity helps explain why 9-Me-BC shows potential across several different applications.
What Does the Research Say About 9-Me-BC?
Reversed dopamine depletion in MPTP neurotoxin models, restoring dopaminergic neurons to normal levels. Improved spatial learning and elevated hippocampal dopamine in 10-day mouse studies. No human clinical trials — preclinical evidence only.
Researchers should consult the latest peer-reviewed literature for the most current findings.
What Is the Recommended 9-Me-BC Dosage?
Standard 9-Me-BC dosing: 15-30 mg daily, administered once daily via oral or subcutaneous.
Half-life: not established. Cycle length: 7-10 days (short cycles recommended due to MAO inhibition).
Use our peptide dosing calculator for exact reconstitution ratios.
Calculate Your 9-Me-BC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 9-Me-BC.
Open Calculator →What Are the Side Effects of 9-Me-BC?
Dose-dependent toxicity at high concentrations in cell cultures. No human safety data available. As an MAO inhibitor, carries risk of tyramine interactions (avoid aged cheese, cured meats, fermented foods). Photosensitivity reported — avoid UV exposure during use.
9-Me-BC is not fda-approved. research compound only. unregulated.
Can You Stack 9-Me-BC With Other Peptides?
Complements other neuroprotective agents like Dihexa and Semax for comprehensive cognitive enhancement. Use caution stacking with serotonergic compounds due to MAO inhibition.
What Is the Bottom Line on 9-Me-BC?
9-Me-BC is a Monoamine oxidase inhibitor, neuroprotective agent researched for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity. Standard protocols use 15-30 mg daily once daily for 7-10 days (short cycles recommended due to MAO inhibition).
Source from COA-tested vendors. Read our beginner's guide for more, or use the dosing calculator to plan your protocol.
Complete Guide
9-Me-BC : Benefits, Dosage, Side Effects & Research
Related Reading
- 9-Me-BC Dosage Guide
- 9-Me-BC Benefits
- 9-Me-BC Side Effects
- 9-Me-BC Stacking Guide
- 9-Me-BC Cycle Guide
- 9-Me-BC Research
Research-Grade Sourcing
If you're going to research 9-Me-BC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 9-Me-BC?
9-Me-BC (9-Methyl-β-carboline) is a Monoamine oxidase inhibitor, neuroprotective agent. Synthetic indole alkaloid derivative targeting dopaminergic neuroprotection. It is researched for dopamine elevation, neuroprotection, improved spatial learning, enhanced dendritic complexity, cognitive enhancement, potential anti-Parkinsonian activity.
What is the recommended 9-Me-BC dosage?
Common dosages: 15-30 mg daily administered once daily via oral or subcutaneous. Cycle length: 7-10 days (short cycles recommended due to MAO inhibition). Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of 9-Me-BC?
Dose-dependent toxicity at high concentrations in cell cultures. No human safety data available. As an MAO inhibitor, carries risk of tyramine interactions (avoid aged cheese, cured meats, fermented foods). Photosensitivity reported — avoid UV exposure during use.
Is 9-Me-BC safe?
9-Me-BC has shown a preliminary safety profile in research. Not FDA-approved. Research compound only. Unregulated. All research should follow appropriate safety protocols.